Phase II study of asparagine-glycine-arginine-human tumor necrosis factor α, a selective vascular targeting agent, in previously treated patients with malignant pleural mesothelioma

Gregorc, V; Zucali, Pa; Santoro, A; Ceresoli, Gl; Citterio, G; DE PAS, Tm; Zilembo, N; DE VINCENZO, F; Simonelli, M; Rossoni, G; Spreafico, A; Vigano', Mg; Fontana, F; DE BRAUD, Fg; Bajetta, E; CALIGARIS CAPPIO, F; Bruzzi, P; Lambiase, A; Bordignon, Claudio